These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8212923)

  • 1. Transient increase of aminotransferases in RA patients treated with methotrexate.
    Lacki JK; Samborski W; Machiewicz SH
    Z Rheumatol; 1993; 52(4):232-5. PubMed ID: 8212923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
    Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
    Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial.
    Iannone F; La Montagna G; Bagnato G; Gremese E; Giardina A; Lapadula G
    J Rheumatol; 2014 Feb; 41(2):286-92. PubMed ID: 24429167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of less frequent monitoring of liver transaminases levels in rheumatic patients treated with low-dose methotrexate.
    Khabbazi A; Kolahi S; Dastgiri S; Hajialiloo M; Nazeri M; Nazeri L; Sheikholeslami Salmasi A; Gader S; Bak Mohammad Zadeh S; Ghasemi A; Poormohammad A
    Int J Rheum Dis; 2014 Jul; 17(6):646-52. PubMed ID: 24965662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice.
    Karlsson Sundbaum J; Eriksson N; Hallberg P; Lehto N; Wadelius M; Baecklund E
    Int J Rheum Dis; 2019 Jul; 22(7):1226-1232. PubMed ID: 31012257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative liver function in patients with rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study.
    Beyeler C; Reichen J; Thomann SR; Lauterburg BH; Gerber NJ
    Br J Rheumatol; 1997 Mar; 36(3):338-44. PubMed ID: 9133966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of serum hepatic aminotransferases during treatment of rheumatoid arthritis with low-dose methotrexate. Risk factors and response to folic acid.
    Suzuki Y; Uehara R; Tajima C; Noguchi A; Ide M; Ichikawa Y; Mizushima Y
    Scand J Rheumatol; 1999; 28(5):273-81. PubMed ID: 10568423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transaminitis and neutropenia are rare in patients on methotrexate: evidence from a large cohort of inflammatory arthritis patients.
    Malley T; Corfield G; Fung P; Heneghan D; Kitchen J
    Rheumatology (Oxford); 2019 Nov; 58(11):2061-2062. PubMed ID: 31081042
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of High-Dose Folic Acid on Methotrexate Efficacies and Safety in Japanese Rheumatoid Arthritis Patients.
    Kameyama S; Kase Y; Kurihara S; Yoshida F; Noda M; Iiduka T; Horiguchi M; Sugiyama K; Hirano T
    Drug Res (Stuttg); 2017 Dec; 67(12):705-709. PubMed ID: 28898908
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver injury following administration of 8-methoxypsoralen during PUVA therapy.
    Bjellerup M; Bruze M; Hansson A; Krook G; Ljunggren B
    Acta Derm Venereol; 1979; 59(4):371-2. PubMed ID: 92158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis.
    Weinblatt ME; Kremer JM; Coblyn JS; Maier AL; Helfgott SM; Morrell M; Byrne VM; Kaymakcian MV; Strand V
    Arthritis Rheum; 1999 Jul; 42(7):1322-8. PubMed ID: 10403258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
    Humphreys JH; Warner A; Costello R; Lunt M; Verstappen SMM; Dixon WG
    Ann Rheum Dis; 2017 Sep; 76(9):1509-1514. PubMed ID: 28341765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis.
    Fries JF; Singh G; Lenert L; Furst DE
    Arthritis Rheum; 1990 Nov; 33(11):1611-9. PubMed ID: 2242059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced hepatotoxicity by total glucosides of paeony in combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
    Chen Z; Li XP; Li ZJ; Xu L; Li XM
    Int Immunopharmacol; 2013 Mar; 15(3):474-7. PubMed ID: 23415907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver enzyme levels in arthritis patients treated with long-term bolus methotrexate.
    Aponte J; Petrelli M; von Dawson N
    Arthritis Rheum; 1992 Jan; 35(1):126-8. PubMed ID: 1346249
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
    Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
    Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune hepatitis as an adverse effect of long-term methotrexate therapy.
    Ksouda K; Affes H; Atheymen R; Ezzeddine M; Zeghal K; Hammami S
    Indian J Pharmacol; 2014; 46(6):649-50. PubMed ID: 25538339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient acute hepatotoxicity of high-dose methotrexate therapy during childhood.
    Weber BL; Tanyer G; Poplack DG; Reaman GH; Feusner JH; Miser JS; Bleyer WA
    NCI Monogr; 1987; (5):207-12. PubMed ID: 3481038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?".
    García DS; Saturansky EI; Poncino D; Martínez-Artola Y; Rosenberg S; Abritta G; Ascimani-Peña C; Cravero A
    Ann Hepatol; 2019; 18(5):765-769. PubMed ID: 31105018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis.
    Genovese MC; van Vollenhoven RF; Pacheco-Tena C; Zhang Y; Kinnman N
    Arthritis Rheumatol; 2016 Jan; 68(1):46-55. PubMed ID: 26473751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.